insights_auto
Nega BOT tushdi 11,11%?
Batafsil oʻrganishchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
0,0080 A$
arrow_downward
-11,11%(-0,00100) 1K
16-noy, 16:10:15 (GMT+11) · AUD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoBOT tikeri uchun statistika yaratilmoqda...
Ochish
0,01 A$
Yuqori
0,01 A$
Past
0,01 A$
Bozor kapitali
19,89 mln
Oʻrtacha hajm
9,99 mln
Hajmi
30,19 mln
52 haftalik eng yuqori
0,15 A$
52 haftalik eng past
0,01 A$
Aksiya boʻyicha daromad
-0,03 A$
Muomaladagi aksiyalar
2,76 mlrd
Xodimlar soni
11
Ochish
0,01 A$
Yuqori
0,01 A$
Past
0,01 A$
Bozor kapitali
19,89 mln
Oʻrtacha hajm
9,99 mln
Hajmi
30,19 mln
52 haftalik eng yuqori
0,15 A$
52 haftalik eng past
0,01 A$
Aksiya boʻyicha daromad
-0,03 A$
Muomaladagi aksiyalar
2,76 mlrd
Xodimlar soni
11
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Business Insider
·
1 soat oldin
A veteran strategist sees a split in the stock market leading to a 15% drop in the S&P 500
Reuters
·
39 daqiqa oldin
S&P 500, Nasdaq futures slide as Nvidia earnings, Anthropic debut loom
Investing.com
·
2 soat oldin
Morgan Stanley raises S&P 500 target on earnings growth, lower oil and AI adoption
Traders Union
·
53 daqiqa oldin
S&P 500 remained close to all-time highs after Nasdaq's drop, Dario Perkins notes
Profil
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Botanix Pharmaceuticals Ltd haqida